Arrowhead Pharmaceuticals (ARWR) Interest Expenses (2022 - 2026)
Arrowhead Pharmaceuticals' Interest Expenses came in at $24.56 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), up 0.7% from $24.38 million a year earlier and up 3.0% from the prior quarter.
Arrowhead Pharmaceuticals (ARWR) Interest Expenses (2022 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Arrowhead Pharmaceuticals reported Interest Expenses of $92.61 million, up 12.5% year-over-year; for FY2025 (ended Sep 30, 2025), it came in at $89.36 million, up 176.2% from FY2024.
- Going back by fiscal year, Interest Expenses was $32.35 million in FY2024 (+76.5%) and $18.33 million in FY2023.
- The fiscal Q3 2026 figure represents the highest quarterly Interest Expenses in data going back to fiscal Q1 2023.
- Year-over-year, Interest Expenses has increased for eight consecutive quarters, with growth averaging 140.3% over the last eight quarters.
- The fastest year-over-year change in Interest Expenses over five years came in fiscal Q3 2025 (growth of 378.6%), and the weakest in fiscal Q3 2024 (a decline of 1.2%).
- Business Quant data shows ARWR's Interest Expenses at $23.85 million (Q2 2026), $22.51 million (Q1 2026) and $21.69 million (Q4 2025) in the three fiscal quarters before Q3 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 281.00 Mn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -462.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -435.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 673.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 247.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Arrowhead Pharmaceuticals | 9.24 Bn | 4.02 Bn | - | 24.56 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 24.56 Mn |
| Mar 31, 2026 | 23.85 Mn |
| Dec 31, 2025 | 22.51 Mn |
| Sep 30, 2025 | 21.69 Mn |
| Jun 30, 2025 | 24.38 Mn |
| Mar 31, 2025 | 21.64 Mn |
| Dec 31, 2024 | 21.65 Mn |
| Sep 30, 2024 | 14.65 Mn |
| Jun 30, 2024 | 5.09 Mn |
| Mar 31, 2024 | 7.24 Mn |
| Dec 31, 2023 | 5.37 Mn |
| Sep 30, 2023 | 5.26 Mn |
| Jun 30, 2023 | 5.16 Mn |
| Mar 31, 2023 | 5.06 Mn |
| Dec 31, 2022 | 2.85 Mn |
Arrowhead Pharmaceuticals Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-expenses&ticker=ARWR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-expenses", "ticker": "ARWR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-expenses&ticker=ARWR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();